Investigation Overview
July 1, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Regulus Therapeutics Inc (NASDAQ:RGLS) shares over potential securities laws violations by Regulus Therapeutics and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the ...
You must register (for free) or login to view the entire investigation.